Osteoarthritis (OA) is the most common form of arthritis, affecting over 32 million Americans. According to the World Health ...

Romosozumab, used in osteoporosis treatment, may offer dual benefits by also reducing the risk for osteoarthritis, notably ...

Researchers found no significant differences in surgical outcomes or follow-up between housed and unhoused patients with ...

IL-1 is considered one of the key mediators involved in the pathogenesis of OA, causing inflammation, joint pain, and ...

Mice with a version of osteoarthritis experienced symptom relief after expression of a protein targeting a stem-cell receptor ...

CHICO, Calif. - Arthritis is a leading reason for euthanizing older pets, but a new treatment called Synovetin OA is offering hope to pet owners. This breakthrough is promising to change the lives of ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

Study in Frontiers in Veterinary Science finds investigational plasmid Elenagen cut osteoarthritis pain by 50 % in dogs and ...

Partnership expected to advance 5x30 strategy by increasing ZILRETTA sales calls and extensively expanding patient access ...

Genascence’s GNSC-001 for knee osteoarthritis receives US FDA regenerative medicine advanced therapy designation: Palo Alto, California Saturday, July 19, 2025, 16:30 Hrs [IST] ...

Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...